Alterations in skin and stratified epithelia by constitutively activated PPARα

Journal of Investigative Dermatology

Volumn 126, Issue 2, 2006, Pages 374-385

  Yang, Qian ^a   Yamada, Atsushi ^a   Kimura, Shioko ^a   Peters, Jeffrey M ^b   Gonzalez, Frank J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; KERATIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DEVELOPMENT; EPIDERMIS HYPERPLASIA; KERATINOCYTE; LACTATION; MAMMARY GLAND; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN; SKIN EPITHELIUM; TONGUE; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; DOXYCYCLINE; EPITHELIUM; FEMALE; KERATINOCYTES; LACTATION; MAMMARY GLANDS, ANIMAL; MICE; MICE, TRANSGENIC; PHORBOL ESTERS; PPAR ALPHA; PREGNANCY; SKIN;

EID: 33644644271     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700056     Document Type: Article

References (64)

1. Akiyama TE, Baumann CT, Sakai S, Hager GL, Gonzalez FJ (2002) Selective intranuclear redistribution of PPAR isoforms by RXR alpha. Mol Endocrinol 16:707-21
2. Akiyama TE, Ward JM, Gonzalez FJ (2000) Regulation of the liver fatty acid-binding protein gene by hepatocyte nuclear factor 1alpha (HNF1alpha). Alterations in fatty acid homeostasis in HNF1alpha-deficient mice. J Biol Chem 275:27117-22
3. Amri EZ, Bonino F, Ailhaud G, Abumrad NA, Grimaldi PA (1995) Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J Biol Chem 270:2367-71
4. Bar-Tana J (2004) Hypolipidemia induced by PPARalpha agonists: HNF-4alpha as an alternative to PPARalpha. Curr Opin Invest Drugs 5:941-6
5. Berger J, Moller DE (2002) The mechanisms of action of PPARs. Annu Rev Med 53:409-35
6. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W (1996) Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137:354-66
7. Braissant O, Wahli W (1998) Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development. Endocrinology 139:2748-54
8. Chen J, Jackson PK, Kirschner MW, Dutta A (1995) Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374:386-8
9. Cheung C, Akiyama TE, Ward JM, Nicol CJ, Feigenbaum L, Vinson C et al. (2004) Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha. Cancer Res 64:3849-54
10. Chiba H, Itoh T, Satohisa S, Sakai N, Noguchi H, Osanai M et al. (2005) Activation of p21CIP1/WAF1 gene expression and inhibition of cell proliferation by overexpression of hepatocyte nuclear factor-4alpha. Exp Cell Res 302:11-21
11. Chung JH, Bell AC, Felsenfeld G (1997) Characterization of the chicken beta-globin insulator. Proc Natl Acad Sci USA 94:575-80
12. Corton JC, Anderson SP, Stauber A (2000) Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu Rev Pharmacol Toxicol 40:491-518
13. Desvergne B, Wahli W (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20:649-88
14. Diamond I, Owolabi T, Marco M, Lam C, Glick A (2000) Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter. J Invest Dermatol 115:788-94
15. Dlugosz AA, Glick AB, Tennenbaum T, Weinberg WC, Yuspa SH (1995) Isolation and utilization of epidermal keratinocytes for oncogene research. Methods Enzymol 254:3-20
16. Eckert RL, Crish JF, Robinson NA (1997) The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol Rev 77:397-424
17. Forman BM, Chen J, Evans RM (1997) Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA 94:4312-7
18. Forman BM, Chen J, Evans RM (1996) The peroxisome proliferator-activated receptors: ligands and activators. Ann NY Acad Sci 804:266-75
19. Glick A, Popescu N, Alexander V, Ueno H, Bottinger E, Yuspa SH (1999) Defects in transforming growth factor-beta signaling cooperate with a Ras oncogene to cause rapid aneuploidy and malignant transformation of mouse keratinocytes. Proc Natl Acad Sci USA 96:14949-54
20. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547-51
21. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766-9
22. Greene ME, Blumberg B, McBride OW, Yi HF, Kronquist K, Kwan K et al. (1995) Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr 4:281-99
23. Hanley K, Jiang Y, Crumrine D, Bass NM, Appel R, Elias PM et al. (1997) Activators of the nuclear hormone receptors PPARalpha and FXR accelerate the development of the fetal epidermal permeability barrier. J Clin Invest 100:705-12
24. Hanley K, Jiang Y, He SS, Friedman M, Elias PM, Bikle DD et al. (1998) Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPARalpha. J Invest Dermatol 110:368-75
25. Hanley K, Komuves LG, Bass NM, He SS, Jiang Y, Crumrine D et al. (1999) Fetal epidermal differentiation and barrier development in vivo is accelerated by nuclear hormone receptor activators. J Invest Dermatol 113:788-95
26. Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ (2001) Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 21:1393-403
27. Henning SJ (1981) Postnatal development: coordination of feeding, digestion, and metabolism. Am J Physiol 241:G199-214
28. Hennings H, Michael D, Cheng C, Steinert P, Holbrook K, Yuspa SH (1980) Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19:245-54
29. Hong J, Samudio I, Liu S, Abdelrahim M, Safe S (2004) Peroxisome proliferator-activated receptor gamma-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins. Endocrinology 145:5774-85
30. Issemann I, Green S (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347:645-50
31. Kersten S, Desvergne B, Wahli W (2000) Roles of PPARs in health and disease. Nature 405:421-4
32. Kersten S, Wahli W (2000) Peroxisome proliferator activated receptor agonists. EXS 89:141-51
33. Kim DJ, Akiyama TE, Harman FS, Burns AM, Shan W, Ward JM et al. (2004) Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis. J Biol Chem 279:23719-27
34. Kim DJ, Murray IA, Burns AM, Gonzalez FJ, Perdew GH, Peters JM (2005) Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity. J Biol Chem 280:9519-27
35. Kliewer SA, Lehmann JM, Willson TM (1999) Orphan nuclear receptors: shifting endocrinology into reverse. Science 284:757-60
36. Komuves LG, Hanley K, Jiang Y, Elias PM, Williams ML, Feingold KR (1998) Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development. J Invest Dermatol 111:429-33
37. Komuves LG, Hanley K, Lefebvre AM, Man MQ, Ng DC, Bikle DD et al. (2000a) Stimulation of PPARalpha promotes epidermal keratinocyte differentiation in vivo. J Invest Dermatol 115:353-60
38. Komuves LG, Hanley K, Man MQ, Elias PM, Williams ML, Feingold KR (2000b) Keratinocyte differentiation in hyperproliferative epidermis: topical application of PPARalpha activators restores tissue homeostasis. J Invest Dermatol 115:361-7
39. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL et al. (1995) Targeted disruption of the alpha isoform of the peroxisome proliferator- activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15:3012-22
40. Lee YS, Yuspa SH, Dlugosz AA (1998) Differentiation of cultured human epidermal keratinocytes at high cell densities is mediated by endogenous activation of the protein kinase C signaling pathway. J Invest Dermatol 111:762-6
41. Li M, Chiba H, Warot X, Messaddeq N, Gerard C, Chambon P et al. (2001) RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations. Development 128:675-88
42. Li M, Indra AK, Warot X, Brocard J, Messaddeq N, Kato S et al. (2000) Skin abnormalities generated by temporally controlled RXRalpha mutations in mouse epidermis. Nature 407:633-6
43. Mandard S, Zandbergen F, Tan NS, Escher P, Patsouris D, Koenig W et al. (2004) The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J Biol Chem 279:34411-20
44. Martin G, Schoonjans K, Lefebvre AM, Staels B, Auwerx J (1997) Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators. J Biol Chem 272:28210-7
45. Matsusue K, Peters JM, Gonzalez FJ (2004) PPARbeta/delta potentiates PPARgamma-stimulated adipocyte differentiation. FASEB J 18:1477-9
46. Michalik L, Desvergne B, Dreyer C, Gavillet M, Laurini RN, Wahli W (2002) PPAR expression and function during vertebrate development. Int J Dev Biol 46:105-14
47. Michalik L, Desvergne B, Tan NS, Basu-Modak S, Escher P, Rieusset J et al. (2001) Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice. J Cell Biol 154:799-814
48. Motojima K, Passilly P, Peters JM, Gonzalez FJ, Latruffe N (1998) Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue-and inducer-specific manner. J Biol Chem 273:16710-4
49. Peters JM, Lee SS, Li W, Ward JM, Gavrilova O, Everett C et al. (2000) Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta). Mol Cell Biol 20:5119-28
50. Pineda Torra I, Jamshidi Y, Flavell DM, Fruchart JC, Staels B (2002) Characterization of the human PPARalpha promoter: identification of a functional nuclear receptor response element. Mol Endocrinol 16:1013-28
51. Ramirez A, Bravo A, Jorcano JL, Vidal M (1994) Sequences 5′ of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation 58:53-64
52. Rivier M, Safonova I, Lebrun P, Griffiths CE, Ailhaud G, Michel S (1998) Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes. J Invest Dermatol 111:1116-21
53. Saez E, Rosenfeld J, Livolsi A, Olson P, Lombardo E, Nelson M et al. (2004) PPAR gamma signaling exacerbates mammary gland tumor development. Genes Dev 18:528-40
54. Schmuth M, Haqq CM, Cairns WJ, Holder JC, Dorsam S, Chang S et al. (2004) Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes. J Invest Dermatol 122:971-83
55. Schmuth M, Schoonjans K, Yu QC, Fluhr JW, Crumrine D, Hachem JP et al. (2002) Role of peroxisome proliferator-activated receptor alpha in epidermal development in utero. J Invest Dermatol 119:1298-303
56. Sher T, Yi HF, McBride OW, Gonzalez FJ (1993) cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 32:5598-604
57. Sherr CJ (1995) D-type cyclins. Trends Biochem Sci 20:187-90
58. Tan NS, Michalik L, Noy N, Yasmin R, Pacot C, Heim M et al. (2001) Critical roles of PPAR beta/delta in keratinocyte response to inflammation. Genes Dev 15:3263-77
59. Targett-Adams P, McElwee MJ, Ehrenborg E, Gustafsson MC, Palmer CN, McLauchlan J (2005) A PPAR response element regulates transcription of the gene for human adipose differentiation-related protein. Biochim Biophys Acta 1728:95-104
60. Tremain R, Marko M, Kinnimulki V, Ueno H, Bottinger E, Glick A (2000) Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras. Oncogene 19:1698-709
61. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H et al. (2003) Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 113:159-70
62. Westergaard M, Henningsen J, Svendsen ML, Johansen C, Jensen UB, Schroder HD et al. (2001) Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid. J Invest Dermatol 116:702-12
63. Winterfield L, Cather J, Menter A (2003) Changing paradigms in dermatology: nuclear hormone receptors. Clin Dermatol 21:447-54
64. Zeng YX, el-Deiry WS (1996) Regulation of p21WAF1/CIP1 expression by p53-independent pathways. Oncogene 12:1557-64